Bath & Body Works' (BBWI) "Outperform" Rating Reiterated at Telsey Advisory Group

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "outperform" rating reissued by investment analysts at Telsey Advisory Group in a research note issued on Tuesday,Benzinga reports. They currently have a $43.00 target price on the stock. Telsey Advisory Group's price objective would suggest a potential upside of 28.13% from the company's current price.

BBWI has been the subject of a number of other reports. Raymond James decreased their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. Barclays upped their price objective on Bath & Body Works from $31.00 to $35.00 and gave the company an "equal weight" rating in a research report on Tuesday. Citigroup lowered their target price on Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a report on Monday, April 7th. The Goldman Sachs Group cut their price target on Bath & Body Works from $49.00 to $42.00 and set a "buy" rating for the company in a research note on Tuesday, April 22nd. Finally, Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $42.31.

Bath & Body Works Trading Down 0.6%

Bath & Body Works stock opened at $33.56 on Tuesday. Bath & Body Works has a 12 month low of $24.96 and a 12 month high of $52.99. The stock has a fifty day simple moving average of $30.05 and a two-hundred day simple moving average of $34.03. The firm has a market cap of $7.15 billion, a price-to-earnings ratio of 8.19, a PEG ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. On average, equities research analysts forecast that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works announced that its board has authorized a stock repurchase plan on Thursday, February 27th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Bath & Body Works by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company's stock valued at $1,093,306,000 after acquiring an additional 208,036 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its position in shares of Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock worth $334,029,000 after purchasing an additional 781,681 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Bath & Body Works by 5.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company's stock valued at $329,317,000 after purchasing an additional 445,887 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after purchasing an additional 6,752,274 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after buying an additional 243,611 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.